Origin and Function of Myofibroblasts in the Liver
The DOI matches its Crossref record.
Abstract
Liver fibrosis contributes to many of the devastating complications of viral, toxic, fatty, and cholestatic liver disease. Understanding the cell populations that promote liver fibrosis and the molecular pathways through which they operate is essential for the development of antifibrotic therapies. The authors review the origins and functions of hepatic myofibroblasts, focusing on hepatic stellate cells, the main contributors to organ fibrosis, and portal fibroblasts, an insufficiently characterized population that may have a specialized function in promoting periductular fibrosis, but a limited role in overall organ fibrosis. They discuss the hypothesis that each fibrogenic cell population in the liver exerts specific functions, and whether cell type-specific antifibrotic strategies are required or whether one therapeutic strategy fits all.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cells are distinct from HSCs with no vitamin A storage and express unique markers such as THY1, fibulin (FBLN)1, FBLN2, MFAP4 (microfibril associated protein 4) and GAS6 (growth arrest specific 6).[135], [136], [137]”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [136]
Citations
Cites
Still being checked.
Cited by
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Self-citationCancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446
Jun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Metadata
- Authors
- Schwabe, R., & Wells, R.
- Affiliations
- Columbia University (US)
- University of Pennsylvania (US)
- Corresponding author
- Wells, Rebecca
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2015-05-14
- Volume
- 35
- Issue
- 02
- Pages
- 097-106
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W617412208
- Cited by
- 86
- References
- 0
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 15 · 2022: 13 · 2021: 3 · 2020: 9 · 2019: 10 · 2018: 11 · 2017: 10 · 2016: 7 · 2015: 1
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- hepatic myofibroblasts, liver fibrosis, hepatic stellate cells, portal fibroblasts, antifibrotic therapy, liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Cell Proliferation, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Origin and Function of Myofibroblasts in the Liver. https://app.cochat.ai/papers/10.1055/s-0035-1550061
- The paper
- Schwabe, R., & Wells, R. (2015). Origin and Function of Myofibroblasts in the Liver. Seminars in Liver Disease. https://doi.org/10.1055/s-0035-1550061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.